Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Assets (2018 - 2025)

TELA Bio (TELA) has 8 years of Assets data on record, last reported at $61.6 million in Q3 2025.

  • For Q3 2025, Assets rose 16.17% year-over-year to $61.6 million; the TTM value through Sep 2025 reached $61.6 million, up 16.17%, while the annual FY2024 figure was $86.6 million, 10.92% up from the prior year.
  • Assets reached $61.6 million in Q3 2025 per TELA's latest filing, down from $67.5 million in the prior quarter.
  • Across five years, Assets topped out at $94.4 million in Q2 2023 and bottomed at $51.3 million in Q2 2022.
  • Average Assets over 5 years is $70.2 million, with a median of $68.8 million recorded in 2021.
  • Peak YoY movement for Assets: soared 83.87% in 2023, then crashed 39.28% in 2024.
  • A 5-year view of Assets shows it stood at $62.5 million in 2021, then grew by 8.49% to $67.9 million in 2022, then increased by 15.02% to $78.0 million in 2023, then grew by 10.92% to $86.6 million in 2024, then decreased by 28.86% to $61.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets were $61.6 million in Q3 2025, $67.5 million in Q2 2025, and $77.3 million in Q1 2025.